A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Clinical trial NCT01283139 · COMPLETED
Trial details
- NCT number
- NCT01283139
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-31
- Primary completion
- 2013-11-14
- Enrollment
- 834
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.